uniQure issued a press release today announcing additional data from the ongoing Phase I/II clinical studies of AMT-130, their investigational gene therapy for Huntington's disease.

Read more: bit.ly/HDF-PR

#uniqure #scientificresearch #researchupdatehd #hdresearch #curehd